Sign in
Subscribe
News
Tech trail
Trade floor
Export
The Killer50
Oxford
Blogs
Awards
Directory
Events
A worldwide window to Cambridge business, innovation and technology
Marshall Land Systems acquired by Canadian investor
Marshall Land Systems, which has its origins in Cambridge UK, has been acquired for an undisclosed sum by Canadian investment firm Flowing River Capital Partners. The sale transfers ownership as part of the Cambridge-based Marshall Group’s long-term strategy.
Cambridge and Oxford star as European DeepTech and Life Science spinouts hit $398bn valuation
DeepTech and life science startups that have spun out of Europe’s universities have a combined value of $398 billion and an increasingly influential position in the region’s technology ecosystem, according to a major new report with input from Cambridge and Oxford.
Quantum Computing boost for Cambridge with input from South Korea
Cambridge has taken a further globally significant step in the field of quantum computing. The Milner Therapeutics Institute in the city, spearheaded by Professor Sir Tony Kouzarides, has stepped on the gas with a new initiative, we can exclusively reveal.
US investors heavily back Artios Pharma $115m Series D growth round
Artios Pharma, a Babraham-based biopharma company realising the therapeutic power of targeting the DNA damage response in cancer, has closed an oversubscribed $115 million Series D financing.
Tencent backs new raise that takes T-Therapeutics Series A to $91m
T-Therapeutics, a Cambridge University biotech spin-out developing next-generation T cell receptor (TCR) therapeutics for cancer and autoimmune disease, has raised a fresh $32 million to bring its Series A haul to date to $91m.
Academia
Sharewatch
Manufacturing
Leukaemia diagnosis may be transformed by AI tool
19 Nov 2025 - 12:00
Towering progress for Cranfield radar as airport tech really takes off
17 Nov 2025 - 12:00
Ötzi wins Postdoc Venture Creation Challenge with ClimateTech gamechanger
17 Nov 2025 - 12:00
Business awards
Entries now being accepted
Business directory
Browse our listings of Cambridge companies
The killer 50
The 50 hottest disruptive technology companies
News
Dizzy heights, jazzed up economics or sheer anarchy? What notes does Budget hit for you?
On the day in history that saw Charlie Parker, Dizzy Gillespie and Miles Davis record what was considered the greatest jazz session ever, and some 30 years later the Sex Pistols released Anarchy In The UK, yesterday our Chancellor announced either the greatest ever package of financial measures or a Budget that could lend itself more towards the latter release.
UK-Canada alliance as BioTryp Therapeutics and Intellisyn Pharma collaborate
University of Cambridge spin-out BioTryp Therapeutics and Intellisyn Pharma – a Montreal based preclinical drug discovery research company – have garnered funding to collaborate on a major R&D project.
Transformational executive hire unveiled by AbOliGo
Cambridge life science business AbOliGo, which is supporting researchers in spatial and single-cell analysis worldwide, has made a significant hire with the arrival of Dr. Ed Ralph as Chief Technology Officer.
Europlaz says UK medtech sector can outpace global competitors
UK medtech firms are being urged to adapt their time-to-market strategies to seize new opportunities and navigate global challenges.
More news
Tech trail
US investors heavily back Artios Pharma $115m Series D growth round
Artios Pharma, a Babraham-based biopharma company realising the therapeutic power of targeting the DNA damage response in cancer, has closed an oversubscribed $115 million Series D financing.
Jabado takes fight for gender equality centre stage at European Parliament
Cambridge influencer Hanadi Jabado, Founder and Managing Partner of Sana Capital, delivered a powerful keynote at the European Parliament during the launch of the landmark Gender Gap in Investments study, positioning Sana Capital as a transformative force in closing Europe's Deep Tech funding gap.
Tencent backs new raise that takes T-Therapeutics Series A to $91m
T-Therapeutics, a Cambridge University biotech spin-out developing next-generation T cell receptor (TCR) therapeutics for cancer and autoimmune disease, has raised a fresh $32 million to bring its Series A haul to date to $91m.
Solar startup powers ahead with global investment
Cambridge Photon Technology (CPT), a DeepTech spin-out from the University of Cambridge, has raised £1.556 million in new funding to accelerate the commercialisation of its photon-multiplier technology.
More Tech trail
Trade floor
UK-Canada alliance as BioTryp Therapeutics and Intellisyn Pharma collaborate
University of Cambridge spin-out BioTryp Therapeutics and Intellisyn Pharma – a Montreal based preclinical drug discovery research company – have garnered funding to collaborate on a major R&D project.
Marshall Land Systems acquired by Canadian investor
Marshall Land Systems, which has its origins in Cambridge UK, has been acquired for an undisclosed sum by Canadian investment firm Flowing River Capital Partners. The sale transfers ownership as part of the Cambridge-based Marshall Group’s long-term strategy.
UK-Canada manufacturing alliance agreed by Make UK and CME
Manufacturing chiefs in Canada and the UK are collaborating to win more global trade for the territories. A trade and partnership agreement has been signed this week by Make UK and its Canadian counterpart, the Canada Manufacturers & Exporters (CME).
Flagship Pioneering companies secure feasibility agreements with GSK
Flagship Pioneering, a Boston US scientific innovation engine for transformative platforms and products, reveals that two companies it founded – ProFound Therapeutics in Boston and Quotient Therapeutics at Chesterford Research Park in Cambridge UK – have clinched separate feasibility agreements with biopharma giant GSK to discover and validate novel targets and therapeutic approaches in respiratory and liver diseases.
Constructive Bio and RxCelerate partner to develop biologic therapeutic candidates
Cambridge companies Constructive Bio and RxCelerate have formed a strategic partnership to develop novel biologic therapeutic candidates targeting multiple disease indications, including liver fibrosis and other cardiometabolic diseases.
More Trade floor
